Story
Morgan Stanley Names UnitedHealth Its Top Managed Care Stock Pick

Summary
Morgan Stanley has designated UnitedHealth Group as its leading stock selection in the managed care industry ahead of second-quarter earnings, citing favorable utilization trends and significant potential from artificial intelligence initiatives.
Morgan Stanley has identified UnitedHealth Group (UNH) as its top pick in the managed care sector, expressing increased confidence in the industry ahead of the upcoming second-quarter earnings season. The investment bank raised its price target on UnitedHealth to $468, noting that recent commentary on healthcare utilization has been reassuring for managed care organizations.
The firm anticipates that UnitedHealth will set a positive tone for the sector when it reports its earnings on July 16. Morgan Stanley analysts are forecasting second-quarter earnings per share for the company to be 10 cents above consensus estimates, attributing this to favorable utilization trends and strong performance at its Optum Health division.
A key factor in Morgan Stanley's analysis is the role of artificial intelligence, which it describes as an "underappreciated earnings driver" for UnitedHealth. The company is reportedly investing $1.5 billion in AI initiatives with the goal of achieving $1 billion in operating cost savings by 2026 through the automation of customer service, claims processing, and other administrative tasks.
AdAccording to the bank, UnitedHealth is positioning itself as an "AI enabler" through its Optum Insight unit, which is developing into an AI-powered platform for healthcare workflows. Morgan Stanley estimates that these AI efforts could lead to a potential 20% upside in earnings per share, excluding any new high-margin revenue from Optum's services.
Other financial firms have also weighed in on UnitedHealth. Bernstein SocGen Group reiterated its Outperform rating, anticipating strong second-quarter results. In a separate analysis, TD Cowen maintained a Buy rating on the company but lowered its price target, citing a reduced outlook for core growth.